ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer.

Lajos Pusztai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.